(Q38294813)

English

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer

scientific article published on 03 January 2008

Statements

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer (English)
Lingbao Ai
Wan-Ju Kim
Berna Demircan
Lisa M Dyer
Kevin J Bray
Ryan R Skehan
Nicole A Massoll
Kevin D Brown
3 January 2008
510-518

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit